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In theWestern world, testicular germ cell cancer (TGCC) is the most common malignancy
of young men. The malignant transformation of germ cells is thought to be caused by
developmental and hormonal disturbances, probably related to environmental and
lifestyle factors because of rapidly increasing incidence of TGCC in some countries.
Additionally, there is a strong genetic component that affects susceptibility. However,
genetic polymorphisms that have been identiﬁed so far only partially explain the risk of
TGCC. Many of the persistent environmental pollutants act through the aryl hydrocarbon
receptor (AHR). AHR signaling pathway is known to interfere with reproductive hormone
signaling, which is supposed to play a role in the pathogenesis and invasive progression
of TGCC. The aim of the present study was to identify whether AHR-related poly-
morphisms were associated with risk as well as histological and clinical features of TGCC
in 367 patients and 537 controls. Haplotype-tagging single-nucleotide polymorphisms
(SNPs) were genotyped in genes encoding AHR and AHR repressor (AHRR). Binary
logistic regression was used to calculate the risk of TGCC, non-seminoma versus
seminoma, and metastasis versus localized disease. Four SNPs in AHRR demonstrated a
signiﬁcant allele association with risk to develop metastases (rs2466287: OR = 0.43,
95% CI 0.21–0.90; rs2672725: OR = 0.49, 95% CI: 0.25–0.94; rs6879758: OR = 0.27,
95% CI: 0.08–0.92; rs6896163: OR = 0.34, 95% CI: 0.12–0.98). This ﬁnding supports the
hypothesis that compounds acting through AHR may play a role in the invasive
progression of TGCC, either directly or through modiﬁcation of reproductive hormone
action.
Keywords: aryl hydrocarbon receptor, aryl hydrocarbon receptor repressor, testicular germ cell cancers, genetic
polymorphisms, genetic variation, association studies, metastasis, histology
INTRODUCTION
Testicular germcell cancer (TGCC) represents themost-frequently
diagnosed cancer in young men between 20 and 40 years of
age. The rates vary considerably according to region and ethnic-
ity, which suggests that both environmental and genetic factors
contribute to TGCC. In Europe, a three- to fourfold increased inci-
dence has been noted during the past 30–40 years, which suggests
that an increased exposure to persistent environmental pollutants
may play an important role.
Common persistent environmental pollutants include dioxins
and polycyclic aromatic hydrocarbons, which exert their toxic
and carcinogenic effects through the ligand-activated transcrip-
tion factor aryl hydrocarbon receptor (AHR). In complex with
its binding partner AHR nuclear translocator (ARNT), it medi-
ates cellular responses to xenobiotic compounds. TheAHR/ARNT
heterodimer stimulates the expression of AHR repressor (AHRR),
which provides a negative feedback regulation by competing with
ARNT for binding to AHR (Mimura et al., 1999).
Testicular germ cell cancer derives from carcinoma in situ (CIS)
cells, also known as intratubular germ-cell neoplasia unclassiﬁed
(Skakkebaek et al., 1982; Oosterhuis and Looijenga, 2005), that
are believed to arise from primordial germ cells that are blocked in
differentiation. The initial malignant transformation of germ cells
is thought to be caused by hormonal disturbances in the microen-
vironment of differentiating germ cells (Skakkebaek et al., 1987;
Sharpe and Skakkebaek, 1993; Rajpert-De Meyts et al., 1998). An
association of TGCC with maternal estrogen and androgen lev-
els in early pregnancy has recently been reported, supporting this
hypothesis (Holl et al., 2009). In addition to altering transcription
of steroidogenic genes, such as cytochrome P450 enzymes, the
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AHR signaling pathway has been shown to interface with estrogen
and androgen receptor signaling (Jana et al., 1999; Kizu et al., 2003;
Safe andWormke,2003; Boverhof et al., 2006; Beischlag et al., 2008;
Kollara and Brown, 2010). Additionally, AHR plays a signiﬁcant
role in tumor promotion and progression by deregulation of cell–
cell contact and inhibition of apoptosis (Mulero-Navarro et al.,
2005; Diry et al., 2006; Carvajal-Gonzalez et al., 2009; Chopra et al.,
2009; Dietrich and Kaina, 2010).
The risk of environment-related carcinogenesis depends not
only on the magnitude of the exposure, but also on individual
susceptibility to the pollutant. Therefore, we aimed to analyze the
association between polymorphic variants of genes encodingAHR
and AHRR and the risk as well as histological and clinical features
of TGCC.
MATERIALS AND METHODS
The cohort consisted of TGCC patients from Sweden and Den-
mark, two neighboring Scandinavian countries, with populations
sharing largely the same genetic background as both descended
from a common ancestral population.
SWEDISH TGCC PATIENTS
All TGCC patients that were referred to the Department of
Oncology, Skåne University Hospital, Lund, the Department of
Oncology, Radiumhemmet or Södersjukhuset, Karolinska Univer-
sity Hospital, Stockholm since March 1996 and November 1998
until October 2006, respectively, were asked to participate in a
study focusing on reproductive function. In total 460 patients
were eligible for the study, of which 75 declined to participate
and 45 were excluded due to linguistic problems, bilateral testicu-
lar cancer, physical handicap, or moving to another region. Seven
patients were excluded due to compromising mental conditions,
10 were excluded due to contra-lateral testicular cancer diagnosed
after inclusion and 3 died of progressive disease before blood sam-
ples were obtained. Among the 320 participants in the study on
reproductive function, no DNA was available for 39. Additionally,
3 patients were excluded due to extra-gonadal germ cell cancer,
leaving the total at 278. All patients gave their informed written
consent and the study was approved by the Ethical Boards of Lund
University and Karolinska Institute.
DANISH TGCC PATIENTS
In the period between 1999 and 2008, DNA was collected from
approximately 300 TGCC patients on the occasion of semen bank-
ing prior to surgery or fertility assessment after treatment. One
hundred sampleswere random selected for this study; the criterion
for selection being sufﬁcient DNA amount. In total, 11 patients
were excluded because of mistaken diagnosis (n = 6), purely extra-
gonadal tumor (n = 4), and in one case because the genetic SNP
analysis failed. Among the remaining 89 patients, 5 presented with
CIS only and were therefore not included in the analysis of distri-
bution of seminomas (SE) versus non-seminomas (NSE). For six
patients no information on stage was available.
CONTROL SUBJECTS
Control subjects were recruited in a study of reproductive func-
tion among Swedish military conscripts aged 18–20 years in the
period 2000–2001 (Richthoff et al., 2002). As part of the investiga-
tion, scrotal palpation and ultrasound was performed in order to
exclude testicular tumors or microcalciﬁcations, which are indica-
tive of an increased risk of CIS. Furthermore, they delivered one
ejaculate for semen analysis as well as a blood sample for assess-
ment of hormone levels. Among the 305 men that were eligible,
214 men with a Swedish mother were selected as control subjects
(Table 1).
GENOTYPING
Genomic DNA was prepared from peripheral leukocytes using
QIAamp DNA Maxi Kit (Qiagen, Germany). All samples
were normalized to the same DNA concentration and the
genotypes were determined using the Sequenom MassArray
MALDI-TOF mass spectrometry. Eleven SNPs in the gene
encoding aryl hydrocarbon receptor (AHR) and 18 SNPs in
the gene encoding aryl hydrocarbon receptor repressor (AHRR)
with a minor allele frequency >0.05 that were identiﬁed as
haplotype-tagging SNPs were selected using dbSNP (available at:
http://www.ncbi.nlm.nih.gov/SNP) and SNP assays were designed
using MassArray Assay Design ver. 2 software (Sequenom Inc.,
USA). Primers were obtained from Metabion GmbH (Germany)
and all reactions were run under the same conditions, except for
the primer annealing temperature of the primary PCR. PCR reac-
tions were performed in a total volume of 6 μL containing 2.5 ng
template DNA, 1.25× Taq PCR buffer (Hotstar, Qiagen), 0.15 U
Taq polymerase (Hotstar, Qiagen), 3.5 nM MgCl2, 0.5 mM dNTP,
and 100 nM of each primer. Ampliﬁcations were performed using
Table 1 | Characteristics of controls and case patients.
Control TGCC-SE TGCC-DK
n (%) n (%) n (%)
n 214 278 89
Age (year) 18 ± 0 31 ± 7 31 ± 8
Histology
NSE 153 (55.0) 34 (38.2)
SE 125 (45.0) 50 (56.2)
CIS only 5 (5.6)
Stage
Localized 200 (71.9) 65 (73.0)
Metastasis 78 (28.1) 18 (20.2)
Unknown 6 (6.7)
Family history ofTGCC
Yes 0 (0) 9 (3.2) 7 (2.3)
No 214 (100) 250 (90.3) 77 (88.5)
Unknown 19 (6.5) 5 (9.2)
History of cryptorchidism
Yes 7 (3.3) 23 (8.3) 13 (14.6)
No 207 (96.7) 247 (88.9) 63 (70.8)
Unknown 8 (2.9) 13 (14.6)
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GeneAmp 9700 machines with dual-384 heads as follows: 95◦C
for 15 min, 45 cycles at 95◦C for 20 s, 56◦C, 60◦C, or 64◦C for
30 s, 72◦C for 60 s, and ﬁnally 72◦C for 3 min. Dephosphoryla-
tion of unincorporated dNTP was achieved using shrimp alkaline
phosphatase. Concentrations of individual homogenous MassEX-
TEND (hME) primers were adjusted to even out peak heights in
the mass spectrum. The extension reactions were carried out by
mixing the adjusted primer mix (containing approximately 1 μM
of each primer) with hME mix containing buffer and 50 μM of
each d/ddNTP mix and 1.25 U of Thermo Sequenase (Amersham
Biosciences, Uppsala, Sweden). PCR ampliﬁcation of hME reac-
tions was performed as follows: 94◦C for 2 min and 99 cycles
at 94◦C for 5 s, 52◦C for 5 s, and 72◦C for 5 s. The samples
were then manually desalted by using 6 mg of Clean Resin and
a dimple plate and subsequently transferred to a 384-well Spec-
troCHIP using a nanodispenser. Randomly selected samples of
each genotypewere directly sequenced in order to validate the SNP
assays.
STATISTICAL ANALYSIS
Single-nucleotide polymorphisms data was processed and ana-
lyzed using the web-based SNPator data analysis suite (Morcillo-
Suarez et al., 2008). Agreement with Hardy–Weinberg equilibrium
was tested using a χ2 goodness-of-ﬁt test. TGCC patients were
divided in two groups depending on whether they were diagnosed
with SE or NSE. Logistic regression association was used to calcu-
late the odds ratio (OR) and 95% conﬁdent interval for developing
TGCC, for developing either SE or NSE, and for developing dis-
seminated disease [deﬁned by stages II, III, and IV according to
the Royal Marsden Hospital staging classiﬁcation (Husband and
Koh, 2004), with stage I disease deﬁned as tumor conﬁned to
the testis, with no evidence of metastases]. In the latter analysis
histological subtype was included as a covariant in the logistic
regression. Associations were considered statistically signiﬁcant at
p < 0.05. Assuming a co-dominant additive model, we tested a
linear trend of increasing effect in the different genotypes using
linear-by-linear association χ2 statistics (SPSS ver. 21). Linkage
disequilibrium (LD; i.e., non-random association of alleles) was
assessed for each gene. The LD between identiﬁed SNPs was deter-
mined by pairwise comparisons of correlation coefﬁcient between
SNPs (r) and the likelihood that recombination has occurred
between SNPs (D′). Since we expected that the selected SNPs
have a small contribution to TGCC and we regard our study to
be exploratory rather than conﬁrmatory, we have chosen to avoid
correction for multiple testing. This may increase the risk of type
1 errors, but it prevents type 2 errors.
RESULTS
No signiﬁcant deviations from Hardy–Weinberg equilibrium were
detected for the SNPs included in the analysis.
We did not ﬁnd a statistically signiﬁcant association between
the studied polymorphisms and the risk of TGCC.
For four SNPs in AHRR a signiﬁcant allele association with
the occurrence of disseminated disease was observed (Table 2).
Patients with metastatic disease had signiﬁcantly lower frequen-
cies of the minor rs2466287 G, rs2672725 G, rs6879758 C, and
rs6896163 G alleles compared to patients with localized disease
(5 vs 10%, 6 vs 11%, 2 vs 5%, and 2 vs 6%, respectively), which
were associated with 57, 51, 73, and 66%, reduced per allele OR
for developing metastatic TGCC, respectively. Heterozygous car-
riers of AHRR variants rs6879758 and rs6896163 had a 74 and
67% reduced risk of developing metastatic TGCC, respectively.
Due to very low frequencies, or even absence, of homozygous car-
riers of the AHRR variants the OR could not be calculated for
these groups of patients. However, trend analyses demonstrated
signiﬁcant associations for all four AHRR variants.
Polymorphisms inAHRR did not show a signiﬁcant association
with risk of TGCC or histological subtype, which was also the
case for SNPs in AHR. Histological subtype and the occurrence
of metastasic disease were not associated with SNPs in AHR. LD
analysis demonstrated a high correlation between rs2466287 and
rs2672725 as well as between rs6879758 and rs6896163 (Table 3).
When analyzed in the two populations individually, similar
statistically signiﬁcant ORs for the four SNPs were observed in the
Swedish population as compared to the combined population. The
associations in the Danish populations showed similar tendencies,
although these did not reach statistical signiﬁcance.
DISCUSSION
In this study we have analyzed associations between SNPs in genes
encoding AHR and AHRR and the risk of developing TGCC, his-
tological subtype, and the occurrence of metastasis. Whereas no
associations were found with SNPs in AHR, four variants in AHRR
associated signiﬁcantly with the occurrence of metastatic disease.
BothAHRand its negative regulatorAHRRare ligand-activated
transcription factors that belong to the family of basic helix-loop-
helix Per-Arnt-Sim (bHLH-PAS) proteins. They are ubiquitously
expressed in almost all human tissues, with levels particularly
high in the testis (Burbach et al., 1992; Tsuchiya et al., 2003).
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the most well-
characterized exogenous ligand of AHR and it is known for its
anti-estrogenic properties such as inhibition of estradiol-induced
uterine weight increase and decreased levels of estrogen and
progesterone receptors in uterus of rat and mice (Safe, 1995).
Several epidemiological studies have shown that TCDD pro-
motes cancer, and experiments in AHR-deﬁcient mice have
shown that AHR is essential for the tumor-promoting effects of
TCDD (Andersson et al., 2002; McMillan and Bradﬁeld, 2007).
Conversely, transgenic mice with a constitutively active AHR
spontaneously develop tumors, their weights of testis and ven-
tral prostate are decreased and the epididymal sperm reserve is
reduced (Brunnberg et al., 2011). Furthermore, AHRR, the nega-
tive regulator of AHR signaling, functions as a tumor suppressor
in multiple human tumors (Zudaire et al., 2008; Li et al., 2012).
Several studies have shown that the AHR activation also inter-
feres with reproductive health. An increased incidence of TGCC
has been observed in workers exposed to TCDD (Kogevinas et al.,
1997) and dioxins have been reported to reduce sperm number,
and to decrease accessory sex gland weight and anogenital distance
in rats (Mably et al., 1992; Gray et al., 1995; Sommer et al., 1996;
Faqi et al., 1998; Ohsako et al., 2002).
While SNPs in either AHR or AHRR did not associate with the
risk of TGCC, it is interesting that an association was observed
between AHRR and dissemination of TGCC, since AHR signaling
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Table 3 | Linkage disequilibrium (D ′) and correlation coefficients (r )
between SNPs inAHRR that associate with metastaticTGCC in the
total population.
rs2466287 rs2672725 rs6879758
D ′ r D ′ r D ′ r
rs2466287
rs2672725 0.978 0.909
rs6879758 0.239 0.172 0.230 0.155
rs6896163 0.195 0.142 0.186 0.132 0.999 0.948
is indeed known to contribute to the control of cell adhesion
and migration (Carvajal-Gonzalez et al., 2009; Dietrich and Kaina,
2010). Apotential role of AHRsignaling indisseminationof TGCC
is further supported by Koliopanos et al. (2002) who reported
that AHR agonists decreased anchorage-independent pancreatic
cancer cell growth.
Since testicular cancer rarely occurs before the onset of puberty,
the malignant transformation of CIS cells may be associated
with activation of the hypothalamic–pituitary–gonadal axis. An
interaction between AHR signaling and steroid or gonadotropic
hormones could therefore be an alternativemechanismunderlying
the association between AHRR polymorphisms and metastatic
TGCC.
A strength of our study is the access to two independent TGCC
populations. Although not all ﬁndings reached statistical signif-
icance in the Danish cohort when the countries were analyzed
separately, most probably due to the limited number of cases
in this group, the same trends with similar relative risks were
found, which strengthens the relevance of our ﬁndings. We cannot
exclude that a small fraction of the TGCC patients in our cohort
were fromnon-Caucasianbackground. However, noneof the allele
frequencies of the analysed SNPs deviated from Hardy-Weinberg
equilibrium, which indicates that either the non-Caucasian allele
frequencies did not differ from those in the Caucasian popula-
tion, or that non-Caucasians did not signiﬁcantly contribute to the
total cohort. The SNPs identiﬁed in this study are intronic poly-
morphisms, thus excluding structural changes in the proteins that
these genes encode. Yet, polymorphisms in non-coding regions
can still play an important role in the regulation of gene expres-
sion, e.g., by affectingmRNAstability, regulationby intronicmicro
RNAs, or potential splice sites. The identiﬁed SNPs could also be
in LD with other genetic polymorphisms that are causally related
to TGCC.
In summary, we have identiﬁed polymorphic variants in the
gene encoding AHRR that associated with risk of disseminated
TGCC. This supports our hypothesis that the AHR signaling path-
way may affect the progression of TGCC, possibly by interfering
with reproductive hormone actions.
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